Key facts
- Corsmed’s last known valuation is $12.2M (Dec 2024).
- It has raised $7.1M; the latest was Accelerator/Incubator in Jul 2025.
- Notable investors include Endeavor Greece, Nolsterby Invest, Andreas Ehn, Big Pi Ventures, ForeC — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Corsmed
- ·The full record, as it builds
Funding rounds
No funding rounds for Corsmed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Corsmed
Developer of an MRI simulation and training software platform designed to provide realistic MRI practice and skills development without requiring physical scanner access. The company's platform simulates real MRI scanner controls, protocol adjustments, and patient setup in an interactive virtual environment with performance feedback and structured training modules, enabling universities, hospitals, imaging centers, and MRI professionals to deliver scalable, safe, and flexible MRI education that improves skills and reduces training time.
- Sector
- Healthcare
- HQ
- Stockholm, Sweden
- Founded
- 2016
- Employees
- 27
- Website
- corsmed.com/
- Ownership
- Privately Held (backing)
Corsmed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Corsmed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Corsmed in its N-PORT filings yet. We sweep new filings monthly.